186 related articles for article (PubMed ID: 3622948)
41. Colloidal bismuth subcitrate in peptic ulcer disease.
Tytgat GN
S Afr Med J; 1986 Jul; 70(1):31-3. PubMed ID: 3523793
[TBL] [Abstract][Full Text] [Related]
42. Effects of the new anti-ulcer agent 12-sulfodehydroabietic acid monosodium salt on healing of acetic acid-induced gastric ulcers in rats.
Onoda Y; Iwasaki H; Magaribuchi T; Tamaki H
Arzneimittelforschung; 1991 May; 41(5):546-8. PubMed ID: 1898427
[TBL] [Abstract][Full Text] [Related]
43. Effect of repeated colloidal bismuth subcitrate treatment on the response of the rat gastric mucosa to the presence of luminal ethanol.
Hinsull SM; Bellamy D
Gut; 1990 Apr; 31(4):389-96. PubMed ID: 2338263
[TBL] [Abstract][Full Text] [Related]
44. Colloidal bismuth subcitrate causes sustained release of gastric mucosal prostaglandin E2.
Mertz-Nielsen A; Steenberg P; Neumark T; Bukhave K; Rask-Madsen J
Aliment Pharmacol Ther; 1991 Apr; 5(2):127-33. PubMed ID: 1888815
[TBL] [Abstract][Full Text] [Related]
45. Effects of sucralfate, cimetidine and rabeprazole on mucosal hydroxyproline content in healing of ethanol-hcl-induced gastric lesions.
Arisawa T; Shibata T; Kamiya Y; Nagasaka M; Nakamura M; Fujita H; Hasegawa S; Harata M; Nakamura M; Mizuno T; Tahara T; Ohta Y; Nakano H
Clin Exp Pharmacol Physiol; 2006 Jul; 33(7):628-32. PubMed ID: 16789931
[TBL] [Abstract][Full Text] [Related]
46. Protective action of vinpocetine against experimentally induced gastric damage in rats.
Nosálová V; Machová J; Babulová A
Arzneimittelforschung; 1993 Sep; 43(9):981-5. PubMed ID: 8240463
[TBL] [Abstract][Full Text] [Related]
47. [Comparison of colloidal bismuth subcitrate with ranitidine in healing and relapse of Campylobacter pylori-associated duodenal ulcers].
Hu FL; Jia BQ; Gao HZ
Zhonghua Nei Ke Za Zhi; 1990 Jun; 29(6):339-41, 382. PubMed ID: 2269032
[TBL] [Abstract][Full Text] [Related]
48. The role of colloidal bismuth subcitrate in gastric ulcer and gastritis.
Tytgat GN; Rauws E; Langenberg W
Scand J Gastroenterol Suppl; 1986; 122():22-9. PubMed ID: 3535018
[TBL] [Abstract][Full Text] [Related]
49. A scanning electron microscopic morphological and semi-quantitative evaluation of rat stomach treated with colloidal bismuth subcitrate and alcohol.
Winters C; Hinsull SM; Gregory Z
Scanning Microsc; 1991 Jun; 5(2):541-7; discussion 547-8. PubMed ID: 1947936
[TBL] [Abstract][Full Text] [Related]
50. Morphologic evaluation of gastric mucosal protection by colloidal bismuth subcitrate (De-Nol).
van den Hoven WE; Birtwhistle RD; Hall DW
Int J Tissue React; 1988; 10(5):297-304. PubMed ID: 3250943
[TBL] [Abstract][Full Text] [Related]
51. [Comparison of the effectiveness of anti-ulcer drugs and their influence on angiogenesis in healing of experimental chronic gastric ulcer].
Hnatyszyn A
Ann Acad Med Stetin; 1995; 41():183-91. PubMed ID: 8615543
[TBL] [Abstract][Full Text] [Related]
52. [Misoprostol and de-nol in the treatment of patients with cimetidine-resistant stomach ulcer].
Stasiewicz J; Raimer M; Kozuszyńska M; Szałaj W; Slezak L
Pol Arch Med Wewn; 1989 Jan; 81(1):21-9. PubMed ID: 2515527
[TBL] [Abstract][Full Text] [Related]
53. Pharmacological properties of colloidal bismuth subcitrate (CBS, DE-NOL).
Wieriks J; Hespe W; Jaitly KD; Koekkoek PH; Lavy U
Scand J Gastroenterol Suppl; 1982; 80():11-6. PubMed ID: 6962539
[TBL] [Abstract][Full Text] [Related]
54. Nocloprost, a unique prostaglandin E2 analog with local gastroprotective and ulcer-healing activity.
Konturek SJ; Brzozowski T; Drozdowicz D; Krzyzek E; Garlicki J; Majka J; Dembinski A; Stachura J; Amon I
Eur J Pharmacol; 1991 Apr; 195(3):347-57. PubMed ID: 1868881
[TBL] [Abstract][Full Text] [Related]
55. Colloidal bismuth subcitrate-induced changes on gastric mucosal hemodynamics in the rat: gastric mucosal blood flow after CBS treatment.
Eleftheriadis E; Kotzampassi K; Tzartinoglou E; Salem A; Aletras H
Gastroenterol Jpn; 1991 Jun; 26(3):283-6. PubMed ID: 1889688
[TBL] [Abstract][Full Text] [Related]
56. Experimental evaluation of Bocopa monniera on rat gastric ulceration and secretion.
Rao CV; Sairam K; Goel RK
Indian J Physiol Pharmacol; 2000 Oct; 44(4):435-41. PubMed ID: 11214498
[TBL] [Abstract][Full Text] [Related]
57. A potential mechanism of action of colloidal bismuth subcitrate: diffusion barrier to hydrochloric acid.
Lee SP
Scand J Gastroenterol Suppl; 1982; 80():17-21. PubMed ID: 6962540
[TBL] [Abstract][Full Text] [Related]
58. Maintenance therapy with colloidal bismuth subcitrate reduces duodenal ulcer relapse.
Bardhan KD; Singh S; Morris P; Thompson M; Hinchliffe RF; Cary BA; Wall RM; Blakemore CB
Ital J Gastroenterol Hepatol; 1997 Apr; 29(2):128-34. PubMed ID: 9646192
[TBL] [Abstract][Full Text] [Related]
59. Treatment of the gastric stump ulcer: an open study with five drugs.
Janke A; Stasiewicz J; Namiot Z; Szalaj W
Hepatogastroenterology; 2000; 47(34):1195-8. PubMed ID: 11020913
[TBL] [Abstract][Full Text] [Related]
60. Likelihood of relapse of duodenal ulcer after initial treatment with cimetidine or colloidal bismuth subcitrate.
Miller JP; Hollanders D; Ravenscroft MM; Tweedle DE; Martin DF
Scand J Gastroenterol Suppl; 1982; 80():39-42. PubMed ID: 6761851
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
